Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Conditions:   Thyroid Carcinoma;   Metastatic Thyroid Carcinoma
Interventions:   Device: PET/CT Scan;   Drug: Iodine-124
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 4, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments